This paper presents detailed analysis of the surveys conducted during the 2026 CSR. It outlines the survey process, design, and response rates, together with stakeholder views on trends, developments, and policy challenges facing Fund members over the next 5–10 years. It also examines stakeholder views on value-added, evenhandedness and traction of Fund surveillance, and their views on future surveillance priorities.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: